François Radvanyi Selected Research

François Radvanyi Research Topics

Disease

32	Neoplasms (Cancer) 01/2022 - 12/2004
23	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 03/2010
14	Carcinoma (Carcinomatosis) 03/2020 - 01/2003
5	Retinoblastoma (Glioblastoma, Retinal) 01/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 03/2014 - 09/2008
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2010
2	Non-Muscle Invasive Bladder Neoplasms 10/2019 - 09/2010
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2021
1	Tertiary Lymphoid Structures 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Necrosis 01/2019
1	Virus Diseases (Viral Diseases) 11/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2013
1	Adenocarcinoma 11/2013
1	Carcinoma in Situ 01/2012
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2008
1	Squamous Cell Carcinoma of Head and Neck 05/2007
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007
1	Carcinogenesis 01/2006

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2006
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2006
8	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 01/2003
7	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2004
4	Phenobarbital (Luminal)FDA Link 11/2021 - 04/2008
4	Messenger RNA (mRNA)IBA 10/2019 - 05/2005
4	ErbB Receptors (EGF Receptor)IBA 10/2015 - 05/2006
3	ChromatinIBA 11/2021 - 09/2006
3	Biological ProductsIBA 01/2021 - 05/2005
3	ParaffinIBA 01/2020 - 04/2007
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 12/2004
3	Small Interfering RNA (siRNA)IBA 03/2014 - 10/2009
2	Cell-Free Nucleic AcidsIBA 12/2021 - 01/2021
2	Gemcitabine FDA Link 03/2020 - 01/2015
2	Phosphotransferases (Kinase)IBA 11/2018 - 09/2017
2	Growth Factor ReceptorsIBA 09/2017 - 03/2010
2	RNA (Ribonucleic Acid)IBA 11/2016 - 01/2011
2	Formaldehyde (Formol)FDA Link 11/2016 - 04/2007
2	Protein Isoforms (Isoforms)IBA 03/2005 - 12/2004
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022
1	CytokinesIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	ProteomeIBA 01/2021
1	InterferonsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	mesoglycanIBA 12/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020
1	Methotrexate (Mexate)FDA LinkGeneric 03/2020
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	KinesinsIBA 11/2019
1	c-Mer Tyrosine KinaseIBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 09/2017
1	Insulin (Novolin)FDA Link 09/2017
1	LigandsIBA 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017
1	PlatinumIBA 01/2015
1	SaltsIBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	Histones (Histone)IBA 12/2013
1	DecorinIBA 12/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2012
1	rab GTP-Binding ProteinsIBA 01/2012
1	Cadherins (E-Cadherin)IBA 03/2010
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2010
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2008
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 09/2008
1	Estrogen ReceptorsIBA 04/2008
1	Tyrosine Kinase InhibitorsIBA 05/2006
1	Mitogen-Activated Protein KinasesIBA 05/2006
1	Gefitinib (Iressa)FDA Link 05/2006
1	Viral DNAIBA 10/2005
1	CarcinogensIBA 01/2005
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2004
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004

Therapy/Procedure

11	Therapeutics 12/2021 - 10/2009
4	Cystectomy 01/2022 - 10/2019
3	Drug Therapy (Chemotherapy) 03/2020 - 01/2019
2	Immunotherapy 01/2021 - 11/2016
1	Radiotherapy 12/2020
1	Neoadjuvant Therapy 03/2020
1	Adjuvant Chemotherapy 03/2020